Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.67 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.67 |
| ▸ | SLC7A5 | Q01650 | 2/20 | 0.45 |
| ▸ | ENPEP | Q07075 | 4/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 4/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.36 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.36 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.36 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.36 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.36 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.36 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.36 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Threonine SCHEMBL971052 | 1.00 | PTGS1 (0.67) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL4493265 | 1.00 | PTGS1 (0.67) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL27769582 | 1.00 | PTGS1 (0.67) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL6391173 | 0.93 | PTGS1 (0.57) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL6391172 | 0.93 | PTGS1 (0.57) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL23883208 | 0.93 | PTGS1 (0.57) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Leucine SCHEMBL3495955 | 0.91 | SLC7A5 (0.62) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Isoleucine SCHEMBL3374935 | 0.89 | PTGS1 (0.53) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Cystine SCHEMBL9051990 | 0.89 | PTGS1 (0.53) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 | |
| Threonine SCHEMBL17559245 | 0.89 | PTGS1 (0.53) | PTGS1SLC7A11SLC7A5ENPEPSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110020242-A1 | HIGH-DENSITY LIPOPROTEIN-LIKE PEPTIDE-PHOSPHOLIPID SCAFFOLD (\"HPPS\") NANOPARTICLES | UNIVERSITY HEALTH NETWORK (CA) | 2011-01-27 | — | — | US | claimed |
| EP-2229411-A1 | HIGH-DENSITY LIPOPROTEIN-LIKE PEPTIDE-PHOSPHOLIPID SCAFFOLD (\"HPPS\") NANOPARTICLES | University Health Network (CA) | 2010-09-22 | — | — | EP | claimed |
| WO-2009073984-A1 | HIGH-DENSITY LIPOPROTEIN-LIKE PEPTIDE-PHOSPHOLIPID SCAFFOLD ('HPPS') NANOPARTICLES | UNIVERSITY HEALTH NETWORK (CA) | 2009-06-18 | — | — | WO | claimed |
| WO-2024076136-A1 | FUSION PEPTIDE COMPLEX COMPRISING TRANSMEMBRANE DOMAIN AND USE THEREOF | 주식회사 안단테에프엠 | 2024-04-11 | — | — | WO | disclosed |
| WO-2024049232-A1 | ANTIBACTERIAL PEPTIDE CONSISTING OF TRANSMEMBRANE PEPTIDE DOMAIN AND BASIC OR POLAR AMINO ACIDS AT OPPOSITE ENDS THEREOF AND VARIANTS THEREOF | 주식회사 안단테에프엠 | 2024-03-07 | — | — | WO | disclosed |
| EP-2362778-B1 | COMPOSITIONS COMPRISING VITAMIN C | TUTINO MARCO (IT) | 2018-02-07 | — | — | EP | disclosed |
| EP-2362778-A2 | COMPOSITIONS COMPRISING VITAMINS | Tutino, Matteo (IT) | 2011-09-07 | — | — | EP | disclosed |
| US-20110206792-A1 | COMPOSITIONS COMPRISING VITAMINS | TUTINO MATTEO | 2011-08-25 | — | — | US | disclosed |
| CN-101052411-B | VLP-antigen conjugates and their uses as vaccines | CYTOS BIOTECHNOLOGY AG | 2011-04-06 | — | — | CN | disclosed |
| EP-2271602-A2 | SURFACTANT-BASED MONOLITHIC COLUMNS, METHODS FOR MAKING THE SAME, AND METHODS FOR USING THE SAME | Georgia State University Research Foundation, Inc. (US) | 2011-01-12 | — | — | EP | disclosed |
| US-7829321-B2 | Method for the production of bacterial toxins | BAXTER INTERNATIONAL INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-20020165344-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-11-07 | — | — | US | disclosed |
| EP-0831872-A4 | POLYPEPTIDE COMPOUNDS THAT FORM BETA SHEETS | TORREY PINES INST (US) | 2002-10-28 | — | — | EP | disclosed |
| US-20020061555-A1 | Method for the production of bacterial toxins | BAXTER HEALTHCARE S.A. (CH) | 2002-05-23 | — | — | US | disclosed |
| WO-2001074862-A2 | METHOD FOR THE PRODUCTION OF BACTERIAL TOXINS | BAXTER INTERNATIONAL INC. (US) | 2001-10-11 | — | — | WO | disclosed |
| EP-0831872-A1 | POLYPEPTIDE COMPOUNDS THAT FORM BETA SHEETS | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1996037212-A1 | POLYPEPTIDE COMPOUNDS THAT FORM β SHEETS | TORREY PINES INSTITUTE FOR MOLECULAR STUDIES (US) | 1996-11-28 | — | — | WO | disclosed |
| WO-1994012205-A1 | DYNORPHIN A SUPPRESSION OF NATURAL KILLER CELL ACTIVITY | THE ROCKEFELLER UNIVERSITY (US) | 1994-06-09 | — | — | WO | disclosed |
| EP-0056249-B1 | SYNTHETIC ANTIGENIC COMPOSITION AND PROCESS FOR MAKING SAME | New York Blood Center, Inc. (US) | 1985-06-26 | — | — | EP | disclosed |
| EP-0056249-A2 | Synthetic antigenic composition and process for making same | New York Blood Center, Inc. (US) | 1982-07-21 | — | — | EP | disclosed |